Leap Motion Controller-based training for upper extremity rehabilitation in children and adolescents with physical disabilities: A randomized controlled trial.

Children and adolescents with conditions like juvenile idiopathic arthritis, cerebral palsy, or brachial plexus birth injury often need hand and arm rehabilitation, and therapists are always weighing whether newer technology-based approaches add anything over standard care. This trial compared an eight-week program using a Leap Motion Controller, a device that tracks hand movements for interactive digital exercises, against conventional upper extremity rehabilitation, across all three diagnostic groups. Over 100 children were enrolled and 92 completed treatment.

Both groups showed improvements on hand function, grip strength, and daily activity measures after treatment, but when the two treatment approaches were compared directly against each other, no statistically significant difference was found between them for any diagnosis group. This suggests the motion-controller training performed comparably to standard therapy rather than outperforming it. A key limitation is that the trial did not include an untreated comparison group, so improvements over time cannot be fully separated from the effects of either treatment alone.

If your child has juvenile idiopathic arthritis, cerebral palsy, or a brachial plexus birth injury affecting hand or arm function, you may wonder whether newer technology-based therapies work better than standard hands-on rehabilitation. This study looked at that question using a device called the Leap Motion Controller, which tracks hand movements during interactive exercises, comparing it to usual therapy over eight weeks in over 100 children with these three conditions. Both the motion-controller group and the standard therapy group showed improvements in hand strength, function, and daily activities by the end of treatment.

However, when researchers compared the two approaches directly, they found no statistically significant difference between them, meaning the motion-controller training did not show an advantage over conventional therapy in this study. This is a moderately sized trial, and because there was no group that received no treatment at all, it is hard to know how much of the improvement came from either therapy specifically versus other factors like time or natural progress.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This randomized controlled trial compared eight weeks of Leap Motion Controller-based training (LMCBT) against conventional upper extremity rehabilitation in 103 enrolled children and adolescents with juvenile idiopathic arthritis, cerebral palsy, or brachial plexus birth injury, with 92 completing treatment. Outcomes included the Duruoz Hand Index, Jebsen Taylor Hand Function Test, nine-hole peg test, Childhood Health Assessment Questionnaire, and grip and pinch strength. Within-group analyses showed statistically significant pre-post improvements across almost all outcomes in both arms for each diagnostic subgroup, with effect sizes ranging widely by condition and outcome (for example, ES 0.31 to 2.65 for LMCBT and 0.12 to 1.66 for conventional treatment in the juvenile idiopathic arthritis subgroup).

Critically, between-group comparisons showed no statistically significant differences between LMCBT and conventional treatment across any parameter in any disease group (P > .05). These findings indicate that LMCBT produced comparable outcomes to standard care rather than superior ones. The absence of a no-treatment control limits causal attribution of within-group gains to either intervention specifically.

Subgroup analyses across three distinct diagnoses, while clinically relevant, further reduce statistical power for detecting between-group differences, and replication with larger samples and a control arm would strengthen confidence in these results.